Clinical waste may prove valuable for monitoring treatment response in ovarian cancer

A microchip-based device developed by Massachusetts General Hospital investigators may greatly simplify the monitoring of patients’ response to treatment for ovarian cancer — the most lethal form of gynecologic cancer — and certain other malignancies. The team reports using their device to isolate and identify tumor cells from ascites, an accumulation of fluid in the abdomen that often occurs in abdominal cancers.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/mgh…


Hacer un comentario